These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2111658)

  • 1. Determination of optimal dosage regimen for amikacin in healthy volunteers by study of pharmacokinetics and bactericidal activity.
    Garraffo R; Drugeon HB; Dellamonica P; Bernard E; Lapalus P
    Antimicrob Agents Chemother; 1990 Apr; 34(4):614-21. PubMed ID: 2111658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum bactericidal activity of aztreonam, cefoperazone, and amikacin, alone or in combination, against Escherichia coli, Klebsiella pneumoniae, Serratia marcescens, and Pseudomonas aeruginosa.
    Van Laethem Y; Husson M; Klastersky J
    Antimicrob Agents Chemother; 1984 Aug; 26(2):224-7. PubMed ID: 6435515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum bactericidal activity and postantibiotic effect in serum of patients with urinary tract infection receiving high-dose amikacin.
    Van der Auwera P; Klastersky J
    Antimicrob Agents Chemother; 1987 Jul; 31(7):1061-8. PubMed ID: 3116918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Piperacillin-amikacin combinations: killing curves].
    Chanal M; Sirot J; Chanal C; Cluzel M; Sirot D; Joly B
    Pathol Biol (Paris); 1990 Sep; 38(7):682-9. PubMed ID: 2122398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of factors affecting in vivo aminoglycoside activity in an experimental model of gram-negative endocarditis.
    Potel G; Caillon J; Le Gallou F; Bugnon D; Le Conte P; Raza J; Lepage JY; Baron D; Drugeon H
    Antimicrob Agents Chemother; 1992 Apr; 36(4):744-50. PubMed ID: 1503436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative evaluation of five aminoglycosides for treatment.
    Rosin H; Naumann P; Reintjens E; Köhler M
    Int J Clin Pharmacol Biopharm; 1976 Apr; 13(3):157-67. PubMed ID: 820656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bactericidal activity and killing rate of serum from volunteers receiving pefloxacin alone or in combination with amikacin.
    Van der Auwera P; Klastersky J; Lieppe S; Husson M; Lauzon D; Lopez AP
    Antimicrob Agents Chemother; 1986 Feb; 29(2):230-4. PubMed ID: 3087276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination therapy: a way to limit emergence of resistance?
    Michéa-Hamzehpour M; Pechère JC; Marchou B; Auckenthaler R
    Am J Med; 1986 Jun; 80(6B):138-42. PubMed ID: 3088999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic activity of trimethoprim and amikacin against gram-negative bacilli.
    Parsley TL; Provonchee RB; Glicksman C; Zinner SH
    Antimicrob Agents Chemother; 1977 Sep; 12(3):349-52. PubMed ID: 410362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of beta-lactamase expression on susceptibility of local isolates of Enterobacter cloacae, Serratia marcescens and Pseudomonas aeruginosa to beta-lactam antibiotics.
    Ramadan MA; Tawfik AF; Shibl AM
    Chemotherapy; 1995; 41(3):193-9. PubMed ID: 7656665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of dosage schedule on the efficacy of gentamicin, tobramycin, or amikacin in an experimental model of Serratia marcescens endocarditis: in vitro-in vivo correlation.
    Potel G; Caillon J; Fantin B; Raza J; Le Gallou F; Lepage JY; Le Conte P; Bugnon D; Baron D; Drugeon H
    Antimicrob Agents Chemother; 1991 Jan; 35(1):111-6. PubMed ID: 2014965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antimicrobial effectiveness of sisomicin. I: In vitro activity of sisomicin compared with gentamicin, tobramycin, amikacin and kanamycin (author's transl)].
    Schassan HH
    Infection; 1976; 4(2):35-41. PubMed ID: 789246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The postantibiotic effect of amikacin alone and in combination with piperacillin on gram-negative bacteria.
    Isaksson B; Hanberger H; Maller R; Nilsson LE; Nilsson M
    Scand J Infect Dis Suppl; 1990; 74():129-32. PubMed ID: 2129064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of increasing doses of amikacin with or without piperacillin in the serum bactericidal test.
    Lagast H; Pascual-Lopez A; Dejace P; Klastersky J
    Eur J Clin Microbiol; 1986 Feb; 5(1):98-102. PubMed ID: 3084248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamics of amikacin in vitro and in mouse thigh and lung infections.
    Craig WA; Redington J; Ebert SC
    J Antimicrob Chemother; 1991 May; 27 Suppl C():29-40. PubMed ID: 1830302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of resistance after therapy with antibiotics used alone or combined in a murine model.
    Pechère JC; Marchou B; Michéa-Hamzehpour M; Auckenthaler R
    J Antimicrob Chemother; 1986 Mar; 17 Suppl A():11-8. PubMed ID: 3086276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of once- and thrice-daily dosing of aminoglycosides in in-vitro models of infection.
    Blaser J
    J Antimicrob Chemother; 1991 May; 27 Suppl C():21-8. PubMed ID: 1906863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamic effects of extended dosing intervals of imipenem alone and in combination with amikacin against Pseudomonas aeruginosa in an in vitro model.
    McGrath BJ; Lamp KC; Rybak MJ
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1931-7. PubMed ID: 8239608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of in vitro critical inhibitory concentration, a novel approach to predict in vivo synergistic bactericidal effect of combined amikacin and piperacillin against Pseudomonas aeruginosa in a systemic rat infection model.
    Chan E; Zhou S; Srikumar S; Duan W
    Pharm Res; 2006 Apr; 23(4):729-41. PubMed ID: 16554956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One shot of high-dose amikacin: a working hypothesis.
    Yourassowsky E; Van der Linden MP; Crokaert F
    Chemotherapy; 1990; 36(1):1-7. PubMed ID: 2106415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.